Male lower urinary tract symptoms: treatment with α-blockers, 5-α-reductase inhibitors, antimuscarinics, or a combination

被引：2
|
作者：
Rodney A. Appell
机构：
[1] Baylor College of Medicine,Department of Urology
来源：
Current Urology Reports | 2007年 / 8卷 / 5期
关键词：
Benign Prostatic Hyperplasia; Lower Urinary Tract Symptom; International Prostate Symptom Score; Tamsulosin; Tolterodine;
D O I：
10.1007/s11934-007-0033-5
中图分类号：
学科分类号：
摘要：
Pharmacological therapy is now considered a firstline treatment for men with moderate to severe lower urinary tract symptoms. Given the success of antimuscarinic agents, α-sympathetic blockers, and 5-α-reductase inhibitors in treating symptoms, the interest in combination therapy has grown. Despite this, large-scale trials to test the efficacy of such combination therapy are still lacking.
引用
收藏
页码：370 / 372
页数：2
相关论文
共 50 条
  • [1] Combination 5-αreductase inhibitors and α-blockers for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Clarke J.C.
    Yoost T.R.
    Clarke Jr. H.S.
    Current Urology Reports, 2008, 9 (4) : 291 - 294
  • [2] α-Blockers and Antimuscarinics for Male Lower Urinary Tract Symptoms: The Search Goes On
    Gratzke, Christian
    Andersson, Karl-Erik
    EUROPEAN UROLOGY, 2013, 63 (01) : 166 - 167
  • [3] Antimuscarinics, β-3 Agonists, and Phosphodiesterase Inhibitors in the Treatment of Male Lower Urinary Tract Symptoms An Evolving Paradigm
    Osman, Nadir I.
    Aldamanhori, Reem
    Mangera, Altaf
    Chapple, Christopher R.
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : 337 - +
  • [4] Combination treatment for male lower urinary tract symptoms with anticholinergic and alpha-blockers
    Gomelsky, Alex
    Kelly, Emily F.
    Dalton, David C.
    CURRENT OPINION IN UROLOGY, 2018, 28 (03) : 277 - 283
  • [5] Antimuscarinics and α-blockers or α-blockers Monotherapy on Lower Urinary Tract Symptoms - A Meta-analysis
    Hao, Nan
    Tian, Ye
    Liu, Wei
    Wazir, Romel
    Wang, Jianzhong
    Liu, Liangren
    Wang, Kunjie
    Li, Hong
    UROLOGY, 2014, 83 (03) : 556 - 562
  • [6] Review: Adding α1-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men
    Lim, Lionel S.
    Sperling, Brian
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (06)
  • [7] Addition of Antimuscarinics to Alpha-blockers for Treatment of Lower Urinary Tract Symptoms in Men: A Meta-analysis
    Xin, Zhixiang
    Huang, Yiran
    Lu, Jun
    Zhang, Qi
    Chen, Chen
    UROLOGY, 2013, 82 (02) : 270 - 277
  • [8] Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms
    Giuliano, Francois
    EUROPEAN UROLOGY, 2008, 53 (06) : 1121 - 1123
  • [9] Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH
    Gravas, Stavros
    Oelke, Matthias
    WORLD JOURNAL OF UROLOGY, 2010, 28 (01) : 9 - 15
  • [10] Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH
    Stavros Gravas
    Matthias Oelke
    World Journal of Urology, 2010, 28 : 9 - 15
12345